In addition, the mutations of DNAH5, DNAH8, DOCK2, FCGBP, PCDH15, RB1, and ZNF208, were related to the poor OS of HBV‐related HCC patients (Figure 6 B). Here, DOCK2 is linked to hepatocellular carcinoma.